Madrigal Pharmaceuticals (MDGL)
(Delayed Data from NSDQ)
$208.04 USD
-9.92 (-4.55%)
Updated May 8, 2024 04:00 PM ET
After-Market: $207.89 -0.15 (-0.07%) 6:32 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | -5.97 |
EPS Last Quarter | -7.38 |
Last EPS Surprise | -21.78% |
ABR | 1.47 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -21.86 |
Next Year | -13.98 |
EPS (TTM) | -23.09 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 5.30M | 26.69M | 82.61M | 315.76M |
# of Estimates | 3 | 6 | 7 | 7 |
High Estimate | 7.60M | 41.10M | 108.30M | 509.00M |
Low Estimate | 1.30M | 14.63M | 61.00M | 153.08M |
Year ago Sales | 0.00M | 0.00M | NA | 82.61M |
Year over Year Growth Est. | NA | NA | NA | 282.22% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -5.97 | -5.35 | -21.86 | -13.98 |
# of Estimates | 6 | 6 | 9 | 9 |
Most Recent Consensus | -6.52 | -6.44 | -24.67 | -18.14 |
High Estimate | -5.45 | -3.75 | -13.67 | -3.72 |
Low Estimate | -6.98 | -6.43 | -26.98 | -23.82 |
Year ago EPS | -4.69 | -5.34 | -19.99 | -21.86 |
Year over Year Growth Est. | -27.29% | -0.19% | -9.35% | 36.05% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 2 | 2 | 3 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 3 | 3 | 4 | 4 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -5.97 | -5.35 | -21.86 | -13.98 |
7 Days Ago | -5.97 | -5.35 | -21.86 | -13.98 |
30 Days Ago | -5.97 | -5.35 | -21.48 | -13.50 |
60 Days Ago | -5.23 | -5.26 | -21.19 | -8.88 |
90 Days Ago | -4.44 | -4.48 | -15.33 | -0.63 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -5.97 | -5.35 | -24.89 | -17.86 |
Zacks Consensus Estimate | -5.97 | -5.35 | -21.86 | -13.98 |
Earnings ESP | 0.00% | 0.00% | -13.85% | -27.75% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -7.38 | -5.68 | -5.34 | -4.69 | NA |
Estimate | -6.06 | -5.32 | -4.78 | -4.47 | NA |
Difference | -1.32 | -0.36 | -0.56 | -0.22 | -0.62 |
Surprise | -21.78% | -6.77% | -11.72% | -4.92% | -11.30% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more